Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, Kuhn J; North American Brain Tumor Consortium study.
Prados MD, et al. Among authors: hess kr.
Neuro Oncol. 2004 Jan;6(1):44-54. doi: 10.1215/S1152851703000292.
Neuro Oncol. 2004.
PMID: 14769140
Free PMC article.
Clinical Trial.